Hirsh Nanda

Janssen Pharmaceutical Companies of Johnson & Johnson

Hirsh Nanda has been at Janssen for 7 years where he currently leads an analytical group that utilizes mass-spectrometry, biophysical assays, and high-throughput automation to support cell line and early development. Prior to joining Janssen, Hirsh held a joint research position at Carnegie Mellon & the National Institute of Standards and Tech (NIST), where he studied the structure & function of membrane proteins. He received his PhD in Biophysics from The Johns Hopkins University.